Drug Database
Back to search

Netherlands· NL-e618624b4ab4

Copiktra 25 mg, harde capsule

A duvelisib product containing duvelisibmonohydraat, registered in Netherlands by Secura Bio Limited. The same ATC class is registered in 6 of our 19 countries.

ATC L01EM04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCopiktra 25 mg, harde capsuleATCL01EM04REGISTER NO.NL-e618624b4ab4PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about duvelisibmonohydraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Duvelisib is registered in 6 of 19 countries.

Countries holding a registration under ATC L01EM04 (duvelisib), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose
Search duvelisib products by name

Duvelisib · ATC L01EM04

6 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DUVELISIBMONOHYDRAAT
Manufacturer
Secura Bio Limited
Country
Netherlands (NL)
ATC code
L01EM04
ATC class
Duvelisib
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/21/1542

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

313 interactions on record for duvelisib.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check duvelisib against other medicinesHow interaction checks work

Duvelisib · interactions on record

313 records

  • 71 severe
  • 234 moderate
  • 8 minor

Most severe, free to view

  • CisaprideA03FA02severe
  • NaloxegolA06AH03severe
  • EliglustatA16AX10severe
  • CilostazolB01AC23severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Duvelisib in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All duvelisib products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9f86f1e-b302-48ab-a2e1-ae5a4ef7365d
GET /v1/drugs/e9f86f1e-b302-48ab-a2e1-ae5a4ef7365d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/copiktra-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Duvelisib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp126025",
  "excipients": [
    "AMMONIA (E 527)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "GELATINE (E 441)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "DUVELISIBMONOHYDRAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2021/05/19",
  "procedure_number": "EMEA/H/C/005381",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/21/1542",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about duvelisib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console